Clinical Trial Update: Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

View source ↗

Summary

A University of Wisconsin–Madison trial evaluating a confounder-corrected quantitative MRI biomarker of hepatic iron content has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemochromatosis
• Hemosiderosis
• Iron Overload

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Iron Overload, Hemochromatosis | Status: COMPLETED